Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Larson

Showing results (1241-1250 of 1,352) with videos related to

Pageof 136
Sort By:
Journal of Neurointerventional Surgery|February 4, 2025
Pre-operative internal maxillary artery embolization for temporomandibular joint replacement: safety and outcomes from a 10-year institutional experienceNanthiya Sujijantarat, Varun Padmanaban, William J Smith, et al.
Cancer Chemotherapy and Pharmacology|November 30, 2011
A phase I trial of docetaxel and pulse-dose 17-allylamino-17-demethoxygeldanamycin in adult patients with solid tumorsGopa Iyer, Michael J Morris, Dana Rathkopf, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 19, 2010
Pharmacokinetic assessment of the uptake of 16beta-18F-fluoro-5alpha-dihydrotestosterone (FDHT) in prostate tumors as measured by PETBradley J Beattie, Peter M Smith-Jones, Yuliya S Jhanwar, et al.
The Lancet. Oncology|June 20, 2018
Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trialMark M Souweidane, Kim Kramer, Neeta Pandit-Taskar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Interferon-gamma and monoclonal antibody 131I-labeled CC49: outcomes in patients with androgen-independent prostate cancerS F Slovin, H I Scher, C R Divgi, et al.
Theranostics|May 7, 2026
Pretargeted <sup>177</sup>Lu/<sup>225</sup>Ac combination therapy of colorectal cancerSara S Rinne, Niloufar Salehi, Brett A Vaughn, et al.
JCI Insight|May 17, 2016
Multiplexed immunofluorescence delineates proteomic cancer cell states associated with metabolismAnup Sood, Alexandra M Miller, Edi Brogi, et al.
Leukemia & Lymphoma|September 15, 2011
High dose cytarabine and mitoxantrone: an effective induction regimen for high-risk acute myeloid leukemia (AML)Sarah M Larson, Nicholas P Campbell, Dezheng Huo, et al.
Journal of the American College of Radiology : JACR|March 15, 2023
White Paper: Best Practices in the Communication and Management of Actionable Incidental Findings in Emergency Department ImagingChristopher L Moore, Andrew Baskin, Anna Marie Chang, et al.
EJNMMI Research|October 8, 2024
[<sup>18</sup>F]TFB PET/CT misses intense [<sup>124</sup>I]iodine-avid metastases after redifferentiation therapy in metastatic thyroid cancerPhilipp Backhaus, Keith S Pentlow, Alan L Ho, et al.
Pageof 136

Showing results (1241-1250 of 1,352) with videos related to

Sort By:
Pageof 136
Journal of Neurointerventional Surgery|February 4, 2025
Pre-operative internal maxillary artery embolization for temporomandibular joint replacement: safety and outcomes from a 10-year institutional experienceNanthiya Sujijantarat, Varun Padmanaban, William J Smith, et al.
Cancer Chemotherapy and Pharmacology|November 30, 2011
A phase I trial of docetaxel and pulse-dose 17-allylamino-17-demethoxygeldanamycin in adult patients with solid tumorsGopa Iyer, Michael J Morris, Dana Rathkopf, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 19, 2010
Pharmacokinetic assessment of the uptake of 16beta-18F-fluoro-5alpha-dihydrotestosterone (FDHT) in prostate tumors as measured by PETBradley J Beattie, Peter M Smith-Jones, Yuliya S Jhanwar, et al.
The Lancet. Oncology|June 20, 2018
Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trialMark M Souweidane, Kim Kramer, Neeta Pandit-Taskar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Interferon-gamma and monoclonal antibody 131I-labeled CC49: outcomes in patients with androgen-independent prostate cancerS F Slovin, H I Scher, C R Divgi, et al.
Theranostics|May 7, 2026
Pretargeted <sup>177</sup>Lu/<sup>225</sup>Ac combination therapy of colorectal cancerSara S Rinne, Niloufar Salehi, Brett A Vaughn, et al.
JCI Insight|May 17, 2016
Multiplexed immunofluorescence delineates proteomic cancer cell states associated with metabolismAnup Sood, Alexandra M Miller, Edi Brogi, et al.
Leukemia & Lymphoma|September 15, 2011
High dose cytarabine and mitoxantrone: an effective induction regimen for high-risk acute myeloid leukemia (AML)Sarah M Larson, Nicholas P Campbell, Dezheng Huo, et al.
Journal of the American College of Radiology : JACR|March 15, 2023
White Paper: Best Practices in the Communication and Management of Actionable Incidental Findings in Emergency Department ImagingChristopher L Moore, Andrew Baskin, Anna Marie Chang, et al.
EJNMMI Research|October 8, 2024
[<sup>18</sup>F]TFB PET/CT misses intense [<sup>124</sup>I]iodine-avid metastases after redifferentiation therapy in metastatic thyroid cancerPhilipp Backhaus, Keith S Pentlow, Alan L Ho, et al.
Pageof 136